Laboratory based investigations of novel drugs and biomarkers

Molecular Biology and Biomarker Development of AKT Inhibition in Gastro-oesophageal Adenocarcinoma.

Queen's University Belfast

School of Medicine, Dentistry and Biomedical Sciences

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

The Upper GI Translational Research group studies biomarkers and drug resistance mechanisms in cancers of the oesophagus, stomach and pancreas.

The group incorporates a comprehensive research programme of research laboratory, tissue and plasma biobanking and a clinical trials in order to translate scientific discoveries into clinical practice.

  • Dr Richard Turkington: School of Medicine, Dentistry and Biomedical Sciences

Contact info

  • View Academic Profile
  • askmhls@qub.ac.uk
  • +44 (0)28 9097 2756

Research Interests

Open to PhD applications in the field of

Make a PhD enquiry

  • Laboratory based investigations of novel drugs and biomarkers
  • Discovery of resistance mechanisms to therapy
  • Innovative biomarker development using clinical samples

Public outreach & key achievements

  • Oesophageal Patients’ Association Dr Turkington is a member of the Oesophageal Patient’s Association (OPA) Steering Committee and am an active participant in outreach and fundraising events for the OPA. The OPA is a patient support and fundraising group for patients with oesophageal cancer and their events are often attended by local MLA’s, providing opportunities to discuss research funding with local government.
  • Friends of the Cancer centre Dr Turkington is also an active fundraiser for the Friends of the Cancer Centre

Research students

PhD Title | Molecular Biology and Biomarker Development of AKT Inhibition in Gastro-oesophageal Adenocarcinoma.

Country | Northern Ireland

PhD Title | Identification of Targetable Mediators of Resistance to Neo-Adjuvant Chemotherapy in Oesophageal Adenocarcinoma

Country | Malaysia

PhD Title | A Pathways-based Approach to Identify Determinants of Drug Resistance in Oesophageal Adenocarcinoma (OAC)

Country | Ireland

PhD Title | Identification of Novel Molecular Biomarkers Predictive of Benefit to Neo-adjuvant Chemotherapy in Oesophageal Adenocarcinoma

Country | Ireland

Discover More

  • Faculty of Medicine, Health and Life Sciences
  • School of Medicine, Dentistry and Biomedical Sciences

Research areas

Laboratory based investigations of novel drugs and biomarkersDevelopmentBiomarkers

Related PhD opportunities